Central Nervous System Therapeutics Market to hit USD 238.8 billion by 2032, says Global Market Insights Inc.
August 20, 2023 20:30 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Aug. 20, 2023 (GLOBE NEWSWIRE) -- Central Nervous System Therapeutics Market size is expected to be worth USD 238.8 billion by 2032. The growing investments in R&D...
Stem Cell Therapy Market Size & Share to Surpass $831.9 Mn by 2030 | Vantage Market Research
August 14, 2023 05:00 ET
|
Vantage Market Research
WASHINGTON, Aug. 14, 2023 (GLOBE NEWSWIRE) -- As per Vantage Market Research, the Global Stem Cell Therapy Market has been steadily growing due to the increasing importance of medical advancements...
NeuroOne® to Report Third Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on August 14
August 08, 2023 16:00 ET
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., Aug. 08, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
Enhancing Care: Expansion of Alpers Disease Treatment Market Size On its Path to US$ 1.90 Billion by 2030, at a 4.57% of CAGR.
June 07, 2023 09:13 ET
|
Zion Market Research
Houston, TX, June 07, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Alpers Disease Treatment Market By Diagnosis (Molecular Genetic Testing, Laboratory...
Neurostimulation Devices Market Revenue is Predicted to Surpass a Valuation of US$ 36.5 billion by 2032, States by Market.us
May 24, 2023 06:57 ET
|
Market.Us
New York, May 24, 2023 (GLOBE NEWSWIRE) -- The Neurostimulation Devices Market stood at US$ 11.1 billion in 2022 and the global market is projected to reach US$ 36.5 billion by 2032. The global...
NeuroOne® to Report Second Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on May 11
May 11, 2023 12:17 ET
|
NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., May 11, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
Exosome Technologies Market Value to Reach USD 343.5 Mn by 2031, rising at a CAGR of 24.8%: TMR Study
May 05, 2023 08:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, May 05, 2023 (GLOBE NEWSWIRE) -- The global exosome technologies market was valued at USD 47.3 Mn in 2022 and is projected to exceed USD 343.5 Mn by 2031. ...
High Intensity Focused Ultrasound (HIFU) Market to Surpass US$ 182.9 Million by 2030, Says Coherent Market Insights (CMI)
March 09, 2023 09:00 ET
|
CMI
Burlingame, March 09, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, Global High-Intensity Focused Ultrasound (HIFU) Market is estimated to be valued at US$ 112.7 million in 2023...
Dystonia Drugs Market Is Expected to Reach $1378.67 Million by 2031: Says AMR
March 08, 2023 20:30 ET
|
Allied Market Research
Portland, OR, March 08, 2023 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global dystonia drugs market was valued at $806.67 million in 2021, and is projected...
ResolutionRx Ltd, a wholly owned subsidiary of RespireRx Pharmaceuticals Inc. Enters into LOI and Term Sheet with Radium Capital for the financing of anticipated Research and Development Credits
February 01, 2023 08:30 ET
|
RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Feb. 01, 2023 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC Markets: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...